Sugi Predict

Sugi Predict / Compounds / SCHEMBL3732241

SCHEMBL3732241

SCHEMBL3732241

N[C@@H](CCC(=O)O)C(=O)OC(=O)[C@@H](N)Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC15A1 P46059 2/20 0.59
▸ LTA4H P09960 3/20 0.56
▸ ALPI P09923 1/20 0.54
▸ PKM P14618 1/20 0.54
▸ PTGS1 P23219 1/20 0.54
▸ XIAP P98170 1/20 0.54
▸ SLC7A5 Q01650 1/20 0.54
▸ CPA3 P15088 1/20 0.53
▸ SLC1A3 P43003 3/20 0.46
▸ SLC1A2 P43004 3/20 0.46
▸ SLC1A1 P43005 3/20 0.46
▸ KEAP1 Q14145 1/20 0.46
▸ NAALAD2 Q9Y3Q0 1/20 0.46
▸ HDAC8 Q9BY41 2/20 0.43
▸ FFAR1 O14842 1/20 0.43
▸ GRM8 O00222 1/20 0.43
▸ GRM6 O15303 1/20 0.43
▸ GRIN2D O15399 1/20 0.43
▸ GRIN3B O60391 1/20 0.43
▸ GSR P00390 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28126901 1.00 SLC15A1 (0.59) SLC15A1LTA4HALPIPKMPTGS1
SCHEMBL4810846 0.89 ALPI (0.53) SLC15A1LTA4HALPIPKMPTGS1
SCHEMBL6259105 0.89 ALPI (0.53) SLC15A1LTA4HALPIPKMPTGS1
SCHEMBL6259112 0.89 ALPI (0.53) SLC15A1LTA4HALPIPKMPTGS1
SCHEMBL8835936 0.88 SLC7A5 (0.68) SLC15A1LTA4HALPIPKMPTGS1
SCHEMBL28820471 0.88 SLC7A5 (0.68) SLC15A1LTA4HALPIPKMPTGS1
SCHEMBL288607 0.88 SLC7A5 (0.68) SLC15A1LTA4HALPIPKMPTGS1
SCHEMBL29160724 0.87 SLC7A5 (0.66) SLC15A1LTA4HALPIPKMPTGS1
SCHEMBL30716634 0.86 NAALAD2 (0.56) SLC15A1LTA4HALPIPKMPTGS1
SCHEMBL8848946 0.84 ALPI (0.54) SLC15A1LTA4HALPIPKMPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114373510-B Metabolic marker for diagnosing or monitoring lung cancer and screening method and application thereof 武汉迈特维尔医学科技有限公司 2023-12-01 — — CN claimed
CN-122045749-A Method for identifying key flavor substances of rice based on materially group science and machine learning 华中农业大学 2026-05-15 — — CN disclosed
US-20250000364-A1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS GLAS USA LLC 2025-01-02 — — US disclosed
US-12089916-B2 Gastrointestinal tract detection methods, devices and systems BIORA THERAPEUTICS, INC. (US) 2024-09-17 — — US disclosed
EP-4252629-A2 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS Biora Therapeutics, Inc. (US) 2023-10-04 — — EP disclosed
EP-3551046-B1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS BIORA THERAPEUTICS INC (US) 2023-07-19 — — EP disclosed
CN-116239545-A Fluorescent probe, preparation method and application thereof 上海理工大学 2023-06-09 — — CN disclosed
WO-2023083197-A1 METABOLIC MARKER FOR DIAGNOSING OR MONITORING LUNG CANCER, AND SCREENING METHOD THEREFOR AND USE THEREOF 武汉迈特维尔医学科技有限公司 2023-05-19 — — WO disclosed
US-20230009902-A1 TREATMENT OF A DISEASE OR CONDITION IN A TISSUE ORGINATING FROM THE ENDODERM GLAS USA LLC 2023-01-12 — — US disclosed
US-11547301-B2 Methods for collecting and testing bacteria containing samples from within the gastrointestinal tract BIORA THERAPEUTICS, INC. (US) 2023-01-10 — — US disclosed
US-20180168490-A1 INGESTIBLE DEVICE AND ASSOCIATED METHODS GLAS USA LLC 2018-06-21 — — US disclosed
WO-2018112389-A1 INGESTIBLE DEVICE AND ASSOCIATED METHODS PROGENITY INC. (US) 2018-06-21 — — WO disclosed
US-20180164221-A1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS BT BIDCO LLC 2018-06-14 — — US disclosed
WO-2018106945-A1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS PROGENITY INC. (US) 2018-06-14 — — WO disclosed
WO-2018106931-A1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS PROGENITY INC. (US) 2018-06-14 — — WO disclosed
WO-2018106933-A1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS PROGENITY INC. (US) 2018-06-14 — — WO disclosed
WO-2018106959-A1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS PROGENITY INC. (US) 2018-06-14 — — WO disclosed
US-9977034-B2 Biomarkers for fatty liver disease and methods using the same Meabolon, Inc. (US) 2018-05-22 — — US disclosed
US-20150377910-A1 Biomarkers for Fatty Liver Disease and Methods Using the Same METABOLON, INC. 2015-12-31 — — US disclosed
US-20100279956-A1 Biomarkers For Fatty Liver Disease And Methods Using The Same METABOLON, INC. 2010-11-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12089916-B2 Gastrointestinal tract detection methods, devices and systems FABP2, SI, MLNR SLC15A1 2624/4885LTA4H 701/4885ALPI 5/4885
US-11547301-B2 Methods for collecting and testing bacteria containing samples from within the gastrointestinal tract SI, VIP, MLN SLC15A1 1392/4885LTA4H 166/4885ALPI 7/4885
US-20250000364-A1 GASTROINTESTINAL TRACT DETECTION METHODS, DEVICES AND SYSTEMS FABP2, SI, MLNR SLC15A1 2624/4885LTA4H 701/4885ALPI 5/4885
US-20230009902-A1 TREATMENT OF A DISEASE OR CONDITION IN A TISSUE ORGINATING FROM THE ENDODERM ALPG, ALPP, FABP2 SLC15A1 4350/4885LTA4H 881/4885ALPI 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.